Short Interest in Autonomix Medical, Inc. (NASDAQ:AMIX) Decreases By 37.7%

Autonomix Medical, Inc. (NASDAQ:AMIX) was the recipient of a significant decrease in short interest in October. As of October 15th, there was short interest totaling 212,000 shares, a decrease of 37.7% from the September 30th total of 340,300 shares. Approximately 4.4% of the company’s stock are short sold. Based on an average trading volume of 424,200 shares, the short-interest ratio is currently 0.5 days. Based on an average trading volume of 424,200 shares, the short-interest ratio is currently 0.5 days. Approximately 4.4% of the company’s stock are short sold.

Autonomix Medical Price Performance

AMIX stock opened at $1.03 on Friday. Autonomix Medical has a fifty-two week low of $0.96 and a fifty-two week high of $17.15. The firm’s 50-day simple moving average is $1.12 and its 200 day simple moving average is $1.40. The stock has a market cap of $6.38 million, a PE ratio of -0.18 and a beta of -2.80.

Autonomix Medical (NASDAQ:AMIX) last released its quarterly earnings data on Wednesday, August 13th. The company reported ($1.07) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.98) by ($0.09). Equities analysts forecast that Autonomix Medical will post -10 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on AMIX shares. Wall Street Zen raised shares of Autonomix Medical to a “sell” rating in a report on Saturday, July 26th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Autonomix Medical in a report on Wednesday, October 8th. Finally, Zacks Research cut shares of Autonomix Medical from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 28th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $5.00.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.